Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
26 Cards in this Set
- Front
- Back
Key characteristics of bacteria
|
• Prokaryotic cell structure
• Cell wall structures – Gram positive (purple) or negative (pink) • Bacterial virulence factors – Lipopolysaccharide (LPS) – Encapsulation • Toxin production and bacterial diseases – Exotoxins • Immune system control of bacterial infections |
|
Gram negative
|
Cell walls contain lipopolysaccharide (LPS)
- aka: Endotoxin - a major inflammatory stimulus - stimulates TLR4 |
|
Capsules
|
Virulence factor commonly exhibited by gram-positive
- Dense outer layer of polysaccharide - Resistance to Complement Lysis - Often anti-phagocytic - Mutants w/o a capsule are avirulent - Adaptive immune response attaches antibodies to capsule - ex: Streptococcus pneumoniae |
|
Virulence factor
|
Some component of a pathogen that allows it to evade or resist an innate or adaptive immune response
- capsules - exotoxins |
|
Toxin‐producing bacteria
|
• Cholera – bacteria stay in gut lumen but produce toxin that causes massive diarrhea
• Tetanus – wound infections by anaerobic bacteria that produces potent neurotoxin • Diptheria – Corynebacterium diphtheria colonizes pharynx and makes toxin that kills epithelial cells in the throat. Forms pseudomembrane. • Toxic shock –toxin "superantigens" produced by staphylococcus aureus cause massive stimulation of T cells to secrete cytokines |
|
Immune system control of bacterial infections
|
Antibodies can directly kill some pathogens by:
1. neutralization of exotoxins--> macrophage ingestion 2. complement activation--> lysis 3. opsonization of capsules--> macrophage ingestion |
|
Life cycle of a virus
|
1. Penetration into host cell cytoplasm
- via specific high-affinity ligand-receptor 2. The virus uncoats, separating nucleic acid from protein shell 3. Viral replication in a host cell 4. Self-assembly 5. Released from infected cell to continue cycle |
|
Viral Latency
|
Ability of a virus to persist in a host indefinitely.
Ex: 1. Herpes simplex- exists in neuronal nucleus as an episomal element (like a plasmid). 2. Hepatitis C- 90% of pts may develop a chronic infection 3. HIV- Retrovirus reverse transcribes into DNA copy that integrates into host chromosome. |
|
Dimorphic Pathogenic Fungi
|
– Candida species normally colonize human skin and are opportunistic pathogens in immunocompromised hosts.
– Cryptococcus neoformans is an opportunistic pathogen that can cause pneumonia if inhaled by immunocompromised hosts. – Histoplasma capsulatum is a soil fungus that causes disease when inhaled. It can resist killing by alveolar macrophages until cell‐mediated immunity enhances their killing activity. – Aspergillus is an opportunistic pathogen that can cause disease when inhaled by immunocompromised hosts. |
|
Pathogenic Parasites
|
Single cell parasites
– Entamoeba histoytica is an amoeba, which lives it life cycle in the intestine and can invade the intestine and cause ulcers. – Plasmodium species cause malaria, which follows a complex life cycle with stages expressed in different cell types and involving a mosquito vector – Trypanosoma species cause African sleeping sickness, syphilis, leprosy. • Multicellular parasites – Worms, such as Shistosomas, can cause chronic debilitating infections |
|
Mechanical barriers to infection
(lo #2) |
- Tight junctions of epithelial cells (skin, gut, lungs, eyes/nose)
- Longitudinal flow of air or fluid (skin, gut) - Movement of muscus by cilia (lungs) |
|
Chemical barriers
(lo #2) |
- Fatty acids (skin)
Antibacterial peptides [defensins] (skin, gut, lungs) - Low pH (gut) - Enzymes [pepsin] (gut) -Salivary enzymes [lysozyme] (eyes/nose) |
|
Microbiological barriers to infection
(lo #2) |
Normal flora
(found on skin & in gut) |
|
Other barriers
(lo #2) |
- Cough & gag reflexes
Prevent aspiration into the lungs to prevent pneumonia - Mechanical methods of removal: intestinal peristalsis, nx urine flow |
|
Inflammatory Response: Roles
(lo #3) |
1. Deliver additional effector molecules & cells to infection site
2. Induce local blood clotting to produce physical barrier to spreading 3. Promote the repair of damaged tissue (which isn't an immunological process) |
|
IL-1beta
|
Local effects:
-Activates vascular endothelium and lymphocytes. -Local tissue destruction. -Increases access of effector cells Systemic Effects: -Fever -Production of IL-6 |
|
TNF-alpha
|
Local effects:
-Activates vascular endothelium & increases vascular permeability, leading to increased entry of IgG, complement, and cells to tissues and increased fluid drainage to lymph nodes. Systemic effects: -Fever -Mobilization of metabolites -Shock |
|
IL-6
|
Local effects:
-Activates lymphocytes -Increased antibody production Systemic effects: -Fever -Induces acute-phase protein production by hepatocytes |
|
CXCL8
|
Local effects:
Chemotactic factor recruits neutrophils, basophils, & T-cells to site of infection (via specific chemotaxis) Systemic effects: n/a |
|
IL-12
|
Local effects:
-Activates NK cells -Induces differentiation of CD4 T-cells into T<h>1-cells Systemic effects: n/a |
|
How does the innate immune system the presence of pathogens?
(lo#4) |
Use "pattern recognition receptors" (PRRs) to detect "pathogen-associated molecular patterns" (PAMPs).
ex: mannose-binding lectin (MBL) binds w/ high affinity only to mannose and fucose residues in proper orientation. |
|
TLR receptor family
|
"toll-like receptor" family
- A set of PRRs that sense extracellular microbial pathogens and initiate innate immune responses -Humans have 10 TLR genes; each encodes a different PRR -TLR recognition of a PAMP is the KEY trigger event in secretion of inflammatory cytokines and chemokines |
|
How does the innate immune system recognize an intracellular (viral) infection?
|
1. RIG-1 & MDA-5 (both PRR sensors) in the cytoplasm detect and bind LONG strands (not nx) of dsRNA.
2. Their binding causes TF's IRF3 & IRF7 to migrate to the nucleus and initiate Type I interferon production. |
|
Type I Interferons
|
Proteins secreted by virally infected cells that can interfere w/ viral replication in fresh cells.
Activates multiple innate immune effectors: -Induce resistance to viral replication in all cells -Increase MHC class I expression & antigen presentation in all cells -Activate dendritic cells & macrophages -Activate NK cells to kill virus-infected cells |
|
How do NK cells recognize and eliminate virually infected cells?
(lo #6) |
1. NK cell doesn't kill Nx cells b/c NK inhibitory receptors recognize Nx cell's MHC class I expression.
- This opposes the activating receptors on NK cells 2. Altered cells or those w/o MHC class I expression cannot stimulate the inhibitory receptor. Therefore the NK cell is triggered by signals from its activating receptors. - This causes NK granule release & induces apoptosis in the abNX cell |
|
NK cell
|
-Develops in bone marrow from lymphoid lineage.
-Nx circulates throughout blood -Activated by Type I interferons (& others), increasing capacity to kill virally-infected cells by 20-100X |